Gaelle Douillard

Gaelle Douillard has extensive work experience in the field of preclinical research and development. Gaelle is currently employed as a Senior Manager of Preclinical Operations at BrainEver since February 2019. Prior to that, they worked at Diaccurate as an R&D Manager from February 2018 to February 2019. In this role, they were responsible for the preclinical development of a therapeutic antibody, project management, and establishing collaborative relationships with partners.

From March 2017 to February 2018, Gaelle was the Head of the Preclinical Department at Invectys. Gaelle'sresponsibilities included conducting in-vitro and in-vivo preclinical studies in immuno-oncology projects, developing therapeutic antibodies and DNA vaccinations, and selecting nonclinical CROs. Gaelle also served as the Head of the Biology Department at Invectys from January 2016 to March 2017, where they performed similar duties.

Gaelle's previous experience includes working as a Confirmed Research Scientist at GlaxoSmithKline from September 2011 to January 2016. In this role, they specialized in drug discovery programs related to inflammation, skin disorders, metabolic disorders, and new antibiotic development. Gaelle conducted screening of drugs, molecular mechanism characterization, and other related tasks.

Gaelle started their career as a Clinical Research Associate at Clinsearch in December 2001, where they managed epidemiologic data, coordinated activities, and managed clinical trials. Gaelle also has experience as a Postdoctoral Visiting Fellow at the University of Pittsburgh from December 2008 to April 2011 and December 2009 to December 2008. Gaelle completed their Ph.D. in Genetics at Institut Cochin from September 2005 to December 2008.

Gaelle Douillard obtained a DU degree in Recherche Clinique from the Université de Caen Normandie in 2002. Following this, they pursued their PhD in Genetics (Biology and biotechnology) at the Université Paris Cité from 2005 to 2008.